Aldesleukin Active Not Recruiting Phase 2 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02027935Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4
NCT01754376Combined BRAF-Targeted Therapy & Immunotherapy for Melanoma